Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Plastikkirurgisk Center Århus Speciallægecenter ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7%   Bankruptcy risk   0.5% 0.5% 0.5% 0.6% 0.6% 0.6% 7.6% 7.4%   Credit score (0-100)   99 99 98 96 97 98 9 10   Credit rating   AA AA AA A A A BB BB   Credit limit (kDKK)   2,359.1 3,047.9 3,654.2 4,612.4 4,894.6 6,368.9 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   3,809 4,429 5,239 6,675 4,959 7,934 0.0 0.0   EBITDA   2,788 3,298 4,025 5,558 3,842 6,686 0.0 0.0   EBIT   2,256 2,753 3,526 5,063 3,384 6,230 0.0 0.0   Pre-tax profit (PTP)   2,331.8 7,422.3 6,559.4 11,462.7 4,565.1 15,062.9 0.0 0.0   Net earnings   1,804.0 6,807.9 5,735.9 9,615.4 4,164.1 12,929.3 0.0 0.0   Pre-tax profit without non-rec. items   2,332 7,422 6,559 11,463 4,565 15,063 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   18,398 18,137 17,797 17,308 16,855 16,874 0.0 0.0   Shareholders equity total   22,160 28,860 34,595 44,098 48,147 60,959 42,115 42,115   Interest-bearing liabilities   10,325 9,667 9,064 8,430 18,047 12,460 0.0 0.0   Balance sheet total (assets)   33,618 39,919 45,053 54,423 67,747 74,588 42,115 42,115   Net Debt   -472 -4,841 -6,587 -12,380 1,253 -7,062 -42,115 -42,115     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   3,809 4,429 5,239 6,675 4,959 7,934 0.0 0.0   Gross profit growth   -1.5% 16.3% 18.3% 27.4% -25.7% 60.0% -100.0% 0.0%   Employees   1 2 2 2 2 2 0 0   Employee growth %   0.0% 100.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   33,618 39,919 45,053 54,423 67,747 74,588 42,115 42,115   Balance sheet change%   2.8% 18.7% 12.9% 20.8% 24.5% 10.1% -43.5% 0.0%   Added value   2,787.5 3,297.7 4,025.5 5,557.7 3,878.7 6,685.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -925 -816 -840 -984 -911 -437 -16,874 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   59.2% 62.2% 67.3% 75.8% 68.2% 78.5% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   9.5% 20.3% 15.6% 23.1% 10.9% 22.2% 0.0% 0.0%   ROI %   9.8% 20.9% 16.2% 23.9% 11.2% 22.6% 0.0% 0.0%   ROE %   8.5% 26.7% 18.1% 24.4% 9.0% 23.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   66.5% 72.3% 76.8% 81.0% 71.1% 81.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -16.9% -146.8% -163.6% -222.8% 32.6% -105.6% 0.0% 0.0%   Gearing %   46.6% 33.5% 26.2% 19.1% 37.5% 20.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   7.7% 0.4% 0.8% 0.5% 15.6% 4.8% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   9.6 14.0 10.8 11.4 2.4 4.2 0.0 0.0   Current Ratio   7.8 14.0 10.8 11.4 2.4 4.2 0.0 0.0   Cash and cash equivalent   10,796.8 14,508.8 15,650.8 20,809.6 16,794.7 19,522.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -217.0 604.4 2,176.4 3,795.8 212.2 1,723.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   2,788 1,649 2,013 2,779 1,939 3,343 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   2,788 1,649 2,013 2,779 1,921 3,343 0 0   EBIT / employee   2,256 1,377 1,763 2,531 1,692 3,115 0 0   Net earnings / employee   1,804 3,404 2,868 4,808 2,082 6,465 0 0